We are live on ! Find out more
AGN

Allergan plc
AGN

Delisted

AGN was delisted on the 8th of May, 2020.

479 hedge funds and large institutions have $16.1B invested in Allergan plc in 2013 Q3 according to their latest regulatory filings, with 65 funds opening new positions, 166 increasing their positions, 194 reducing their positions, and 94 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% more call options, than puts

Call options by funds: $342M | Put options by funds: $171M

9% more capital invested

Capital invested by funds: $14.7B → $16.1B (+$1.39B)

6% less funds holding in top 10

Funds holding in top 10: 3230 (-2)

6% less funds holding

Funds holding: 512479 (-33)

14% less repeat investments, than reductions

Existing positions increased: 166 | Existing positions reduced: 194

31% less first-time investments, than exits

New positions opened: 65 | Existing positions closed: 94

Holders
479
Holders Change
-33
Holders Change %
-6.45%
% of All Funds
15.53%
Holding in Top 10
30
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-6.25%
% of All Funds
0.97%
New
65
Increased
166
Reduced
194
Closed
94
Calls
$342M
Puts
$171M
Net Calls
+$170M
Net Calls Change
+$45M
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
176
Two Sigma Advisers
New York
$7.44M -$1.41M -10,568 -17%
SG Americas Securities
177
SG Americas Securities
New York
$7.38M -$12.8M -95,843 -65%
Aviva
178
Aviva
United Kingdom
$7.25M +$1.58M +11,859 +31%
AP
179
Alydar Partners
Massachusetts
$7.04M +$6.51M +48,858 New
CCM
180
Century Capital Management
Massachusetts
$6.76M
EIM
181
ExxonMobil Investment Management
Texas
$6.64M +$1.41M +10,588 +30%
TSU
182
TD Securities (USA)
New York
$6.57M +$271K +2,034 +5%
ZIM
183
Zacks Investment Management
Illinois
$6.25M -$5.05M -37,921 -47%
ACI
184
AMP Capital Investors
Australia
$6.19M -$4.24M -31,847 -43%
SCA
185
SAC Capital Advisors
Connecticut
$6.18M -$48.6M -364,959 -89%
CCMH
186
Cornerstone Capital Management Holdings
New York
$6.11M -$2.19M -16,440 -28%
RFA
187
Reilly Financial Advisors
California
$6.06M +$28.4K +213 +0.5%
MCM
188
Munder Capital Management
Michigan
$6M -$158K -1,185 -3%
T
189
TOBAM
France
$5.83M -$1.59M -11,942 -23%
FAF
190
Fjarde Ap-fonden
Sweden
$5.76M -$171K -1,283 -3%
GI
191
GAMCO Investors
Connecticut
$5.71M +$2.02M +15,159 +62%
LSA
192
L & S Advisors
California
$5.58M -$123K -927 -2%
AB
193
AT Bancorp
Iowa
$5.54M -$75.9K -570 -1%
RP
194
Realm Partners
New York
$5.51M -$2M -15,050 -28%
BNP Paribas Asset Management
195
BNP Paribas Asset Management
France
$5.3M -$133K -997 -3%
EVM
196
Eaton Vance Management
Massachusetts
$5.29M +$22.9K +172 +0.5%
FTIOP
197
Fiduciary Trust International of Pennsylvania
Pennsylvania
$5.22M +$2.01M +15,081 +71%
RJA
198
Raymond James & Associates
Florida
$5.04M -$2.27M -17,060 -33%
LOM
199
Loeb Offshore Management
New York
$4.74M -$5.82M -43,689 -57%
PAM
200
Panagora Asset Management
Massachusetts
$4.72M +$1.88M +14,110 +75%

AGN Hedge Fund Activity: Q3 2013 in Review

479 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Allergan plc (AGN) for Q3 2013, worth a combined $16.1B — up 9.4% from $14.7B a quarter earlier.

Sellers outnumbered buyers: 94 funds closed out of AGN and 65 opened new positions — a net loss of 29 holders — while 194 trimmed existing stakes and 166 added.

The largest buyer was Viking Global Investors, adding an estimated $244M. The largest seller was OppenheimerFunds, cutting an estimated $440M.

  • 479 institutional investors held Allergan plc (AGN) as of Q3 2013, down from 512 in Q2 2013.
  • Funds reported $16.1B of Allergan plc stock for Q3 2013, up 9.4% quarter-over-quarter.
  • 65 funds opened new Allergan plc positions in Q3 2013 and 94 closed out, a net change of -29 holders.
  • The largest Allergan plc buyer in Q3 2013 was Viking Global Investors, an estimated $244M added.
  • The largest Allergan plc seller in Q3 2013 was OppenheimerFunds, an estimated $440M sold.

Based on aggregated 13F filings for Q3 2013.